IP Library Granted Patent US 12,345,787
Granted Patent B2
US 12,345,787 · App. 18/138,210 · Granted Jul 1, 2025

Magnetic resonance imaging apparatus and control method thereof

Inventors: Nobuyuki Yoshizawa (Chiba, JP); Yoshitaka Bito (Chiba, JP); Takashi Nishihara (Chiba, JP)
Assignee: FUJIFILM Corporation
G01R33/546G01R33/5601G01R33/5602G01R33/5607
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,345,787
App. No.
18/138,210
Granted
Jul 1, 2025
Kind
B2
Abstract

In contrast-enhanced MRI, a visualization capability of a tissue which a contrast agent reaches is increased, and overall imaging time is shortened. An imaging unit of an MRI apparatus includes a gradient echo pulse sequence for acquiring a T1 weighted image including a fat saturation pulse, and a control unit performs control to generate images of a plurality of phases having different arrival positions of a contrast agent by repeating the pulse sequence for a predetermined time from administration of the contrast agent to the subject by the imaging unit. At this time, a preparation pulse that suppresses a signal from a contrast agent present outside a target tissue (cell) is added prior to a pulse sequence, in a phase immediately before reaching the target tissue.

Claims (26)

1. A magnetic resonance imaging apparatus comprising:

an imaging unit configured to apply a high-frequency magnetic field and a gradient magnetic field to a subject, collect a nuclear magnetic resonance signal generated from the subject, and generate an image of the subject, the imaging unit including a pulse sequence configured to acquire a T1 weighted image including a fat saturation pulse; and

a control unit configured to control the imaging unit, wherein

the control unit performs control in imaging to generate images of a plurality of phases having different arrival positions of a contrast agent by repeating the pulse sequence for a predetermined time from administration of the contrast agent to the subject by the imaging unit, and during the imaging and after elapse of the predetermined time, a preparation pulse configured to suppress a signal from the contrast agent present outside an arrival target tissue or cell of the contrast agent is added prior to the pulse sequence in a part of the plurality of phases.

2. The magnetic resonance imaging apparatus according to claim 1 , wherein the imaging unit applies the preparation pulse either before or after the fat saturation pulse.

3. The magnetic resonance imaging apparatus according to claim 2 , wherein the imaging unit uses an MSDE pulse or a bipolar MPG pulse as the preparation pulse.

4. The magnetic resonance imaging apparatus according to claim 1 , wherein

the imaging unit applies a spin labeling pulse as the preparation pulse to outside an imaging region.

5. The magnetic resonance imaging apparatus according to claim 1 , wherein

the pulse sequence configured to acquire the T1 weighted image is a 2D or 3D RF spoiling type gradient echo sequence.

6. The magnetic resonance imaging apparatus according to claim 1 , wherein

the imaging unit includes a comparison unit configured to execute a first pulse sequence to which the preparation pulse is added and a second pulse sequence to which the preparation pulse is not added in a part of the phases, and compare a signal collected by the first pulse sequence with a signal collected by the second pulse sequence.

7. The magnetic resonance imaging apparatus according to claim 6 , wherein

the control unit determines continuation of imaging of a next phase by the imaging unit according to a result of the comparison unit.

8. The magnetic resonance imaging apparatus according to claim 6 , further comprising:

a support information generation unit configured to generate diagnosis support information for the subject based on a result of the comparison unit.

9. The magnetic resonance imaging apparatus according to claim 6 , wherein

the control unit causes a display device to display at least one of a result of the comparison unit and diagnosis support information.

10. The magnetic resonance imaging apparatus according to claim 1 , wherein

the control unit includes a user interface unit configured to receive at least one user setting of a type of the preparation pulse, a signal suppression intensity by the preparation pulse, and an addition position of the preparation pulse in the repetition of the pulse sequence.

11. The magnetic resonance imaging apparatus according to claim 1 , wherein

the arrival target tissue of the contrast agent is a liver, and the plurality of phases includes an arterial phase, a portal venous phase, a transitional phase, and a hepatobiliary phase.

12. A control method for a magnetic resonance imaging apparatus that applies a high-frequency magnetic field and a gradient magnetic field to a subject according to a pulse sequence, collects a nuclear magnetic resonance signal generated from the subject, and generates an image of the subject, the control method comprising:

using a pulse sequence for acquiring a T1 weighted image including a fat saturation pulse to repeat the pulse sequence for a predetermined period of time from administration of a contrast agent to the subject to generate images of a plurality of phases having different arrival positions of the contrast agent; and

during imaging and after elapse of the predetermined time, adding a preparation pulse configured to suppress a signal from the contrast agent present outside an arrival target tissue or cell of the contrast agent prior to the pulse sequence in a part of the plurality of phases.

13. The control method for a magnetic resonance imaging apparatus according to claim 12 , wherein in the repetition of the pulse sequence, the preparation pulse is added when a part of signals of k-space data made of the nuclear magnetic resonance signals is collected.

Assignments (2)
MERGER Recorded Aug 29, 2024
From: FUJIFILM HEALTHCARE CORPORATION
To: FUJIFILM CORPORATION
Reel/Frame 068807/0625 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2023
From: YOSHIZAWA, NOBUYUKI; BITO, YOSHITAKA; NISHIHARA, TAKASHI
To: FUJIFILM HEALTHCARE CORPORATION
Reel/Frame 063414/0684 →
Priority Claims (1)
JP 2022-073311 · Apr 27, 2022 · national
Continuity (1)
Related Publication 20230349995A1 · Nov 2, 2023
References Cited (7)
US 20120003160A1 · Wolf · 2012 [cited by examiner]
US 20190056470A1 · Wang · 2019 [cited by examiner]
US 20240225448A1 · Schuetz · 2024 [cited by examiner]
Yuko Nakamura et al., “Pseudo-random Trajectory Scanning Suppresses Motion Artifacts on Gadoxetic Acid-enhanced Hepatobiliary-phase Magnetic Resonance Images”, Magn. Reson. Med. Sci. doi:10.2463/mrms.mp.2018-0174. [cited by applicant]
Nakayama T. et al., “Balanced MR cholangiopancreatography with motion-sensitized driven-equilibrium (MSDE) preparation: feasibility of Gd-EOB-DTPA-enhanced biliary examination”, Clin. Radiol. Dec. 2016. 71(12):1284-1288. [cited by applicant]
European search report dated Sep. 18, 2023 in connection with European Patent Application No. 23 17 0267. [cited by applicant]
Ohno, T., et al., “Usefulness of breath-hold inversion recovery-prepared T1-weighted two-dimensional gradient echo sequence for detection of hepatocellular carcinoma in Gd-EOB-DTPA-enhanced MR imaging,” Clinical Imaging… [cited by applicant]